Nagaraj Nagathihalli
banner
drnag.bsky.social
Nagaraj Nagathihalli
@drnag.bsky.social
Pancreatic Cancer Researcher. Associate Professor @umiamimedicine and Asst Dir for Basic Science Research at SPCRI (PanCan Inst) @SylvesterCancer. Worked at @VUMC_Cancer. NCI-FDOH funded. Works on signaling, drug resistance, models, immune-TME & Therapies.
Reposted by Nagaraj Nagathihalli
Our cancer prevention experts weigh in on a report released by the U.S. Surgeon General about the cancer risks linked to alcohol: brnw.ch/21wPP3T #EndCancer
Even Small Amounts of Alcohol Can Cause Cancer, Surgeon General Says
The top U.S. health official is calling for all alcoholic beverages to carry a warning label about cancer risk.
brnw.ch
January 6, 2025 at 5:34 PM
Reposted by Nagaraj Nagathihalli
Overview of molecular characteristics of pancreatic cancer from @mskcancercenter.bsky.social @mskdeptofmed.bsky.social with useful data. Reminder that KRAS is 95% of pancreatic cancer (~1% G12C), 10% have germline pathogenic alterations (e.g. BRCA1/2, ATM, PALB2). www.nature.com/articles/s41...
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival - Nature Medicine
Analyses of clinical and genomic data from a cohort of 2,336 patients with pancreatic adenocarcinoma find that KRAS dosage gains are a hallmark of disease progression and are predictive of poor outcom...
www.nature.com
January 6, 2025 at 2:06 PM